脑神经认知性能在髓寡腺细胞糖蛋白抗体相关疾病: 一个系统的审查和元分析

相关实验视频

Updated: Mar 16, 2026

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies

Published on: October 27, 2016

Helvécio N Feitosa Filho¹, João Filipe Cavalcante Uchoa Furtado¹, Eduardo Correia Eulálio¹

¹School of Medicine, University of Fortaleza, Ceará, Brazil.

Multiple sclerosis and related disorders

|March 14, 2026

概括

认知障碍是Myelin oligodendrocyte glycoprotein抗体相关疾病 (MOGAD) 的一个关键特征,特别影响成年人的处理速度和工作记忆. 建议MOGAD患者进行标准化测试,以评估这些认知缺陷.

科学领域:

神经科学是一个神经科学.
神经学神经学
免疫学免疫学免疫学

背景情况:

髓寡腺细胞糖蛋白抗体相关疾病 (MOGAD) 是一种中枢神经系统脱髓化疾病.
虽然已知摩托和视觉影响,但MOGAD的认知影响尚未明确.

研究的目的:

系统地审查和元分析神经心理测试数据,以描述MOGAD中的认知概况.
在成人和儿科MOGAD人群中调查认知障碍.

主要方法:

在PubMed,Embase和Web of Science进行了系统的文献搜索.
包括11项观察性研究,涉及507名患者 (68名儿科,439名成年人).
从经过验证的认知测试 (MoCA,PASAT,SDMT,WISC-V) 中提取和分析数据.

主要成果:

接受MOGAD治疗的成年人表现出轻度的全球认知障碍 (合并的MoCA得分:24.69).
在成年人中,处理速度和工作记忆受到显著影响 (PASAT-3平均值:39.14,PASAT-2平均值:30.91,SDMT平均值:44.47).
儿科MOGAD队列在WISC-V.上显示了大多数认知领域的相对保存.

结论:

认知障碍是MOGAD的一个重要和多样化的方面,主要影响处理速度和工作记忆.
将标准化的认知评估整合到MOGAD患者护理中至关重要.
需要进一步的纵向研究来了解MOGAD的长期认知轨迹.

关键词:

认知障碍认知障碍是一种认知障碍.进行元分析分析.髓寡腺细胞糖蛋白抗体与相关疾病相关的抗体.系统性审查系统性审查

更多相关视频

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...